Text Size

Effects of Atorvastatin on Adiponectin Levels and Insulin Sensitivity In Hypercholesterolemic Patients

This study has been completed.
Sponsor:
Information provided by:
Gachon University Gil Medical Center
ClinicalTrials.gov Identifier:
NCT00745836
First received: September 2, 2008
Last updated: NA
Last verified: September 2008
History: No changes posted
  Purpose

High dose atorvastatin may worsen insulin sensitivity.


Condition Intervention Phase
Hypercholesterolemia
 Drug: statin
 Phase 4

Study Type: Interventional
Study Design: Intervention Model: Parallel Assignment
Primary Purpose: Treatment

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Gachon University Gil Medical Center:

Study Start Date: January 2005
Study Completion Date: August 2008
Arms Assigned Interventions
Experimental: atorvastatin 10 mg, 80 mg Drug: statin

  Eligibility

Ages Eligible for Study:   25 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • hypercholesterolemia

Exclusion Criteria:

  • chronic renal disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00745836

Locations
Korea, Republic of
Gil Medical Center
Incheon, Korea, Republic of, 405760
Sponsors and Collaborators
Gachon University Gil Medical Center
  More Information

No publications provided by Gachon University Gil Medical Center

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

ClinicalTrials.gov Identifier: NCT00745836     History of Changes
Other Study ID Numbers: GMC-200508
Study First Received: September 2, 2008
Last Updated: September 2, 2008
Health Authority: South Korea: Institutional Review Board

Keywords provided by Gachon University Gil Medical Center:
insulin sensitivity

Additional relevant MeSH terms:
Hypercholesterolemia
Insulin Resistance
Hyperlipidemias
Dyslipidemias
Lipid Metabolism Disorders
Metabolic Diseases
Hyperinsulinism
Glucose Metabolism Disorders
Atorvastatin
 Hydroxymethylglutaryl-CoA Reductase Inhibitors
Anticholesteremic Agents
Hypolipidemic Agents
Antimetabolites
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Enzyme Inhibitors
Lipid Regulating Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on June 13, 2013